Mayo Clinic Diet Announces the Beta Launch of Medical Weight Loss Rx Program
Dr. Adam Perlman Joins Pendulum Therapeutics as Chief Medical Officer
SimBioSys and Mayo Clinic Enter Strategic Collaboration
LONDON and NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Intelligent Scopes Corp, a subsidiary of Claritas HealthTech Ltd. is pleased to announce it has entered into a know-how agreement with Mayo...
Mitesh Borad, M.D., will serve as the Principal Investigator for the clinical trialThe Investigator-sponsored clinical trial follows the robust preclinical proof of concept data generated by...
Fresenius Kabi and Mayo Clinic Enter into Agreement for Ivenix® Infusion System
ROCHESTER, Minn., Nov. 15, 2023 /PRNewswire/ -- As part of Mayo Clinic Diet's mission to support communities and individuals wherever they are on their wellness journey, Mayo Clinic Diet has launched a new Rx Companion program. This program is built for those on a weight-loss medication journey—or have access to the clinical care/prescriptions they require—but who need a scientifically-backed platform to ensure sustainable, healthy weight loss success. Now, patients can access a specially designed digital program with the tools, education, and support needed to help manage side effects and ensure lifelong weight management.
Nucleus RadioPharma is making a splash with an oversubscribed $56 million Series A to prop up the CDMO’s manufacturing capacity, with a Rochester, MN site expected to be completed by the end of the year. The raise will also be used to fund the construction of two regional hubs, as well as increase its research and supply chain capabilities.
Mayo Clinic Collaborates with Naveris to Advance Precision Medicine in HPV-driven Head and Neck Cancer with NavDx in DART 2.0 Clinical Trial
ROCHESTER, Minn. and SAN MATEO, Calif., Jan. 10, 2023 /PRNewswire/ -- Mayo Clinic Laboratories, a leading reference laboratory, and Helix, the nation's leading population genomics and viral surveillance company, today announced a new strategic collaboration that will provide biopharma customers access to a comprehensive joint laboratory offering for research and development initiatives across the drug development lifecycle.